Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Banco de datos
País/Región como asunto
Tipo del documento
Revista
País de afiliación
Intervalo de año de publicación
1.
Thorax ; 74(4): 405-409, 2019 04.
Artículo en Inglés | MEDLINE | ID: mdl-29440588

RESUMEN

We report baseline results of a community-based, targeted, low-dose CT (LDCT) lung cancer screening pilot in deprived areas of Manchester. Ever smokers, aged 55-74 years, were invited to 'lung health checks' (LHCs) next to local shopping centres, with immediate access to LDCT for those at high risk (6-year risk ≥1.51%, PLCOM2012 calculator). 75% of attendees (n=1893/2541) were ranked in the lowest deprivation quintile; 56% were high risk and of 1384 individuals screened, 3% (95% CI 2.3% to 4.1%) had lung cancer (80% early stage) of whom 65% had surgical resection. Taking lung cancer screening into communities, with an LHC approach, is effective and engages populations in deprived areas.


Asunto(s)
Servicios de Salud Comunitaria/organización & administración , Detección Precoz del Cáncer/métodos , Neoplasias Pulmonares/diagnóstico por imagen , Áreas de Pobreza , Anciano , Servicios de Salud Comunitaria/métodos , Inglaterra/epidemiología , Femenino , Accesibilidad a los Servicios de Salud , Humanos , Neoplasias Pulmonares/epidemiología , Neoplasias Pulmonares/etiología , Masculino , Tamizaje Masivo/métodos , Persona de Mediana Edad , Unidades Móviles de Salud , Proyectos Piloto , Prevalencia , Fumar/efectos adversos , Tomografía Computarizada por Rayos X
2.
Thorax ; 74(7): 700-704, 2019 07.
Artículo en Inglés | MEDLINE | ID: mdl-30420406

RESUMEN

We report results from the second annual screening round (T1) of Manchester's 'Lung Health Check' pilot of community-based lung cancer screening in deprived areas (undertaken June to August 2017). Screening adherence was 90% (n=1194/1323): 92% of CT scans were classified negative, 6% indeterminate and 2.5% positive; there were no interval cancers. Lung cancer incidence was 1.6% (n=19), 79% stage I, treatments included surgery (42%, n=9), stereotactic ablative radiotherapy (26%, n=5) and radical radiotherapy (5%, n=1). False-positive rate was 34.5% (n=10/29), representing 0.8% of T1 participants (n=10/1194). Targeted community-based lung cancer screening promotes high screening adherence and detects high rates of early stage lung cancer.


Asunto(s)
Detección Precoz del Cáncer/métodos , Neoplasias Pulmonares/diagnóstico , Tamizaje Masivo/métodos , Salud Pública , Fumar/efectos adversos , Tomografía Computarizada por Rayos X/métodos , Anciano , Femenino , Humanos , Incidencia , Neoplasias Pulmonares/epidemiología , Masculino , Persona de Mediana Edad , Proyectos Piloto , Fumar/epidemiología , Reino Unido/epidemiología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA